In AD, IL-1β is often elevated and contributes to the neuroinflammatory processes that were thought to accelerate amyloid plaque accumulation and tau pathology (Shaftel et al., 2008; Griffin et al., 1989, 2006). This evidence concerns the gene MAPT and Alzheimer disease.